N@N

ORASURE TECHNOLOGIES INC (NASDAQ:OSUR), Down By 9.95% ($0.97) From $9.750 After BUYINS.NET Report Predicted Weakness Before Ear

^{Published on 2011-08-03 05:25:09 - WOPRAI}
 

August 3, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Thursday, July 14th 2011 stating that ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) was expected to be Down Before its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=osur&id=178329

At the time this story was written, ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) is Down By 9.95% ($0.97) From $9.750 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) - OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. Its products include OraQuick ADVANCE HIV-1/2, a point-of-care test for antibodies to the human immunodeficiency virus type 1 and type 2; OraQuick HCV, a point-of-care test for antibodies to the hepatitis C virus; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing. The company also offers MICRO-PLATE DOA Assays used to detect drugs in an oral fluid sample; Cryosurgical SystemsProfessional under the Histofreezer trade name for the removal of warts and other benign skin lesions; and Cryosurgical SystemsOTC for the removal of common and plantar warts. In addition, it develops OraQuick HIV-1/2 OTC, a point-of-care oral fluid HIV-1/2 test; Homogeneous DOA Assays; and OraQuick, a point-of-care testing platform. Further, the company sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid western blot HIV-1 confirmatory test; and Q.E.D., a rapid point-of-care saliva alcohol test. Additionally, it offers various diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types, and other medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The company markets its products through direct sales, strategic collaborations, and independent distributors to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities in the United States and internationally. It has collaboration agreements with Merck & Co. Inc. and Roche Diagnostics. The company was founded in 1979 and is based in Bethlehem, Pennsylvania.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. ORASURE TECHNOLOGIES INC (NASDAQ:OSUR) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net